| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |